Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 86
Selected: 0
NCT IDTitle
NCT05128201Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma
NCT03539250Dose Constraints for the Temporal Lobes of Intensity-modulated Radiotherapy Treatment Plans for Nasopharyngeal Carcinoma
NCT04823468Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma
NCT05780372Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma
NCT07013461International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
NCT06496308Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment
NCT02944708Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma
NCT05755009High- and Low-dose Radiotherapy Combined With Envafolimab for Metastatic Solid Tumor
NCT06277050Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
NCT05059613Thalidomide With or Without Probiotics in Radioactive Oral Mucositis
NCT05032014Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver Cancer
NCT05248022Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure
NCT07208487Clinical Study of Pretreatment PET/CT Parameters for Predicting the Efficacy of 125I Seed Implantation in the Treatment of Malignant Tumors
NCT07362810G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation
NCT01616849Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma
NCT06743867The Safety and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Metastatic Adenocarcinoma
NCT02459457A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer
NCT05252078Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
NCT04555226The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)
NCT05955391TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)
NCT04484506Pegaspargase-COEP Chemotherapy Combined With Radiotherapy for Extra-nodal NK/T Cell Lymphoma
NCT06151080Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL
NCT07809139A Clinical Study to Evaluate CHT101 Injection in Subjects With Relapsed/Refractory T-Cell and B-Cell Hematologic Malignancies
NCT06934070Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical Resection
NCT05042791A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases
NCT06259721Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT07368283Limited Target Volume Radiotherapy After Glioblastoma Surgery
NCT03666221Nimotuzumab for Recurrent Nasopharyngeal Carcinoma
NCT06478472Prospective Clinical Study of Orelabrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local Therapy
NCT05221814Pathological Classification of Pulmonary Nodules in Images Using Deep Learning
NCT06991907PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and Safety
NCT07085988Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
NCT06268600The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma
NCT04436965Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition
NCT06362772Clinical Efficacy of 125I Seed Implantation in the Treatment of Refractory Differentiated Thyroid Cancer
NCT01271439Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma
NCT07029464Comparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right Colon Cancer : A Multicenter Propensity Score Matching Analysis
NCT05177237Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma
NCT02143388Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial
NCT06140589Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer
NCT02355249Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer
NCT04319471Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
NCT06762470Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma
NCT04421469Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC
NCT06954259Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With Chemotherapy
NCT04220528Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC
NCT03637634The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study
NCT046854603D Printed Bolus in Post-mastectomy Radiotherapy
NCT06770699Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma
NCT06553352Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma